pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,913 catalysts · 5,256 phase readout · 2,333 8k filing · 321 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 62 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,256
  • 8k filing2,333
  • pdufa321
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07548489: Phenobarbital for Agitated Delirium

Sponsor: Duke University. Phase: PHASE3. Conditions: Agitated Delirium, Delirium Confusional State, Delirium in the Intensive Care Unit, Hyperactive Delirium

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07395050: Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes

Sponsor: City of Hope Medical Center. Phase: EARLY_PHASE1. Conditions: Stage 3 Type 1 Diabetes

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05967468: Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder

Sponsor: Baylor College of Medicine. Phase: NA. Conditions: Obsessive-Compulsive Disorder in Children, Anxiety Disorder of Childhood, Social Anxiety Disorder of Childhood, Obsessive-Compulsive Disorder in Adolescence, Generalized Anxiety Disorder, Separation Anxiety, Panic Disorder, Panic Disorder With Agoraphobia, Panic Attacks

full page →ctgov ↗
›COMPLETEDphase readoutNCT05849168: High-Intensity Interval Training to Improve Symptoms of Deployment-Related Respiratory Disease

Sponsor: University of Colorado, Denver. Phase: NA. Conditions: Occupational Exposure

full page →ctgov ↗
›RECRUITINGphase readoutNCT03593317: Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD

Sponsor: Hospices Civils de Lyon. Phase: PHASE2. Conditions: Arrhythmogenic Right Ventricular Dysplasia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07324291: Perianal MBL-CRE Colonization and Infection in Allogeneic Hematopoietic Stem Cell Transplant Patients

Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: . Conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Carbapenem-resistant Enterobacterales

full page →ctgov ↗
›RECRUITINGphase readoutNCT07426991: Cognitive Performance, Sleep Disturbances and Fatigue in Multiple Sclerosis

Sponsor: Heinrich-Heine University, Duesseldorf. Phase: . Conditions: Multiple Sclerosis, Remitting-Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progress Multiple Sclerosis, Fatigue Syndrome, Chronic, Sleep Disorders

full page →ctgov ↗
›COMPLETEDphase readoutNCT06948890: Effect of Music on Cue Reactivity for Patients With Opioid Use Disorder

Sponsor: Brigham and Women's Hospital. Phase: NA. Conditions: Opioid Use Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07336797: Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy

Sponsor: Abdelrahman Mahmoud. Phase: PHASE2. Conditions: Metabolic Syndrome, Obesity & Overweight, HIV (Human Immunodeficiency Virus)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06435897: Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells

Sponsor: Shenzhen Geno-Immune Medical Institute. Phase: PHASE1. Conditions: Autoimmune Diseases

full page →ctgov ↗
›COMPLETEDphase readoutNCT07453810: Flow- Versus Volume-controlled Ventilation During Robot-assisted Laparoscopic Radical Prostatectomy

Sponsor: Ankara Etlik City Hospital. Phase: NA. Conditions: Positive Pressure Ventilation

full page →ctgov ↗
›RECRUITINGphase readoutNCT06623097: Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality Study

Sponsor: Dana-Farber Cancer Institute. Phase: NA. Conditions: Cancer Survivorship

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06069310: Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma

Sponsor: National and Kapodistrian University of Athens. Phase: . Conditions: Chronic Rhinosinusitis With Nasal Polyps, Severe Eosinophilic Asthma, Chronic Rhinosinusitis Without Nasal Polyps

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07379697: Measuring Local Potentials in PFA. MULTI PFA (EU)

Sponsor: CathVision ApS. Phase: . Conditions: Atrial Fibrillation (AF)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07499310: The Safety and Effectiveness of Q Therapeutic System, Frequency-tuned Electromagnetic Field Treatment in Facilitating the Recovery of Patients With Chronic Stroke.

Sponsor: Kessler Foundation. Phase: NA. Conditions: Stroke, Chronic Stroke Patients

full page →ctgov ↗
›COMPLETEDphase readoutNCT06558513: To Evaluate a Phase I/II Clinical Study of XNW5004 Tablets in Patients With Relapsed/Refractory Advanced Tumors

Sponsor: Evopoint Biosciences Inc.. Phase: PHASE1. Conditions: Advanced Tumor, Lymphoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT00974090: Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes

Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Type 2 Diabetes Mellitus

full page →ctgov ↗
›RECRUITINGphase readoutNCT06398990: The Effect of Cognitive Exercise Therapy Approach and Yoga in Adolescents With Dysmenorrhoea

Sponsor: Acibadem University. Phase: NA. Conditions: Dysmenorrhea, Primary Dysmenorrhea

full page →ctgov ↗
›RECRUITINGphase readoutNCT07389590: Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis

Sponsor: Johns Hopkins University. Phase: PHASE4. Conditions: Multiple Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07230990: Mechanisms Of Orbitofrontal Stimulation in Depression

Sponsor: Subha Subramanian. Phase: NA. Conditions: Major Depressive Disorder (MDD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06465290: Promoting Neuroplastic Changes of Patients With TBI

Sponsor: University of Maryland, Baltimore. Phase: NA. Conditions: Traumatic Brain Injury

full page →ctgov ↗
›COMPLETEDphase readoutNCT02292160: Does the National Health Insurance Card Allow us to Predict Antibiotic Resistance?

Sponsor: University Hospital, Rouen. Phase: . Conditions: Urinary Tract Infection Empiric Antibiotic

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04890834: Dyadic Yoga Intervention for the Improvement of Healthcare Utilization and Quality of Life in Patients With Head and Neck Cancer Undergoing Chemoradiation and Their Caregivers

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Head and Neck Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07341464: Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends

Sponsor: Société des Produits Nestlé (SPN). Phase: NA. Conditions: Cerebral Palsy (CP), Oncology

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07564609: the REMONO-CD and the REMONO-UC Studies

Sponsor: University Hospital, Clermont-Ferrand. Phase: . Conditions: Crohn Disease (CD), Ulcerative Colitis (UC)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07347236: MyNOURISH: Hydrolysed Collagen Supplementation in Older Adults With Fragility Fractures

Sponsor: Hospital Pengajar Universiti Putra Malaysia. Phase: NA. Conditions: Fragility Fracture

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06004232: Prenatal Yoga to Prevent Postpartum Depression

Sponsor: Henry Ford Health System. Phase: NA. Conditions: Postpartum Depression

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07473232: Comparison of Platelet-rich Plasma and Activated Cytokine-rich Serum Injection Treatments in Patients With Knee Osteoarthritis. (KOA PRP ACS)

Sponsor: Pamukkale University. Phase: NA. Conditions: Knee Arthritis Osteoarthritis, Platelet Rich Plasma Injection, Conditioned Serum

full page →ctgov ↗
›COMPLETEDphase readoutNCT07522632: Wearable Device to Assess Mobility After Anterior Iliac Grafting Covered With a Regional Block Technique Transversus Abdominis Plane Block

Sponsor: Ain Shams University. Phase: NA. Conditions: Wearable Device, Mobility, Anterior Iliac Grafting, Regional Block Technique, Transversus Abdominis Plane Block

full page →ctgov ↗
›COMPLETEDphase readoutNCT05785832: A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

Sponsor: Tandem Diabetes Care, Inc.. Phase: NA. Conditions: Type 2 Diabetes Treated With Insulin

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07375732: Transcranial Electrical Stimulation for Noninvasive Study of Menopausal/Perimenopausal Symptoms

Sponsor: Carnegie Mellon University. Phase: NA. Conditions: Menopausal Depression, Menopause Hot Flashes, Menopause, Menopause Related Conditions

full page →ctgov ↗
›RECRUITINGphase readoutNCT01900132: Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: NA. Conditions: Neuromuscular Disease, Motor Neuron Disease, Inherited Neuromuscular Conditions, Inherited Neuropathies

full page →ctgov ↗
›COMPLETEDphase readoutNCT04128332: Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer

Sponsor: CCTU- Cancer Theme. Phase: NA. Conditions: Cancer of Pancreas

full page →ctgov ↗
›RECRUITINGphase readoutNCT07012798: FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma

Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: Hepatocellular Carcinoma (HCC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07346287: ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy

Sponsor: Stratpharma AG. Phase: PHASE4. Conditions: Vaginal Atrophy, Atrophic Vaginitis, Genitourinary Syndrome of Menopause (GSM)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07139106: Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal Thoughts

Sponsor: New York State Psychiatric Institute. Phase: PHASE4. Conditions: Major Depressive Disorder (MDD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07464106: Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults.

Sponsor: Robert Bosch Medical Center. Phase: . Conditions: Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Cardio-Renal Syndrome, Frailty

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06831006: Assessing the Effect of Cool Roofs on Health Using Smartwatches in Colima, Mexico

Sponsor: University of Auckland, New Zealand. Phase: NA. Conditions: Heart Rate, All-day Steps, Distance Walked, Active Minutes, Moderate-intensity Activity Minutes, Vigorous-intensity Activity Duration, Sleep Quantity, Time in Sleep Stages, Awake Duration, Sleep Score

full page →ctgov ↗
›COMPLETEDphase readoutNCT05127733: Online Cognitive Behavioural Therapy for Substance Use Disorder: The Impact of Peer Support

Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Substance Use Disorders

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07467733: Evaluation of the Safety and Preliminary Efficacy of Neuroinduced Mesenchymal Stem Cells and Exosome Therapy in Patients With Spinocerebellar Palsy

Sponsor: Biocells Medical. Phase: PHASE1. Conditions: Spinocerebellar Ataxia - All Sub-types

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07349615: A Study of SHR-1918 In Participants With Hypertriglyceridemia

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd. Phase: PHASE3. Conditions: Hypertriglyceridemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT03735043: Cardiac Output Monitoring by ccNexfin© in Pregnant Women

Sponsor: University Hospital, Lille. Phase: NA. Conditions: Pregnancy

full page →ctgov ↗
›RECRUITINGphase readoutNCT05655078: Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma

Sponsor: University College, London. Phase: NA. Conditions: Malignant Pleural Mesothelioma

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07239843: Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. Phase: . Conditions: Major Depressive Disorder (MDD), Schizophenia Disorder, Bipolar 1 Disorder, Alzheimer Disease, Parkinson Disease, Frontotemporal Dementia (FTD), Dementia With Lewy Bodies (DLB)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07471243: Dressing-related Experiences and Surgical Site Self-care in Hip and Knee Replacement: an Observational Cohort Study

Sponsor: Bournemouth University. Phase: . Conditions: Total Hip Replacement, Total Knee Replacement

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07402135: Fecal Noninvasive Biomarkers Oriented Control Versus Usual Care Strategy in Ulcerative Colitis

Sponsor: Qilu Hospital of Shandong University. Phase: NA. Conditions: Noninvasive Biomarkers, Ulcerative Colitis (UC)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07391878: Evaluate the Safety and Efficacy of TRG-200 KIT in Patients With Refractory Overactive Bladder.

Sponsor: Trigone Pharma Ltd.. Phase: PHASE2. Conditions: Overactive Bladder (OAB)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06538285: Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV

Sponsor: Nicky Mehtani, MD, MPH. Phase: PHASE2. Conditions: Methamphetamine Use Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00580385: Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: NA. Conditions: Osteosarcoma

full page →ctgov ↗
›WITHDRAWNphase readoutNCT06657885: CAbotégravir LENacapavir DUal Long Acting

Sponsor: Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba. Phase: PHASE2. Conditions: HIV1 Infection, Multi-treated Patients Who Have Received Multiple Lines of Antiretroviral Treatment, CABOTEGRAVIR, LENACAPAVIR, Stable Oral Antiretroviral Treatment for at Least 6 Months

full page →ctgov ↗
← prev
page 83 of 159
next →